← Back

International Flavors & Fragrances Inc

International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, and complementary adjacent products in the United States, and internationally. It operates in through Taste, Food Ingredients, Health & Biosciences, and Scent segments. The Taste segment offers savory products such as soups, sauces, meat, fish, poultry, snacks; beverages consists of juice drinks, carbonated or flavored beverages, spirits; sweets comprising, bakery products, candy, cereal, chewing gum; and dairy products, such as yogurt, ice cream, cheese, and other products, as well as spices and seasoning ingredients for meat, food service, convenience, alternative protein and culinary products. The Food Ingredients segment provides natural, artificial, and plant-based specialty food ingredients; natural antioxidants and anti-microbials used for natural food preservation and shelf-life extension for beverages, cosmetic and healthcare products, pet food and feed additives; and savory solutions, such as spices, marinades, and mixtures, and inclusion products comprising combining flavorings with fruit, vegetables and other natural ingredients, as well as soy and pea protein with value-added formulations, emulsifiers and sweeteners. The Health & Biosciences segment offers enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications, as well as engages in health, food biosciences, home and personal care, animal nutrition and grain processing businesses. The Scent segment creates fragrance compounds, and fragrance ingredients. International Flavors & Fragrances Inc. was incorporated in 1909 and is headquartered in New York, New York.

Price · split & dividend adjusted
News & notes moving IFF
IFF

IFF Report Finds GLP-1 Reshaping Food Choices Among Indian Consumers

IFF has released new research showing that GLP-1 medication use is significantly reshaping food choices and eating behaviors among Indian consumers. The study, based on research conducted among GLP-1 users in Delhi, Mumbai and Bengaluru, found that 74% read food labels more carefully, 64% experience social eating discomfort at least occasionally, and 69% are choosing coconut water as part of their hydration habits. Consumers are eating smaller portions, with examples including moving from three to four chapatis to one or two, and from five or six idlis to two. The report also found that 90% experience changes in how food tastes or feels, and 50% prefer soft, easy-to-digest textures. While personal consumption habits are evolving, household purchasing patterns remain relatively stable, with 78% continuing to buy biscuits for their households and 71% continuing to buy packaged sweets and full-fat dairy products.
Business Wire·2dRead more ▾
IFF

Ingredients, Flavors & Fragrances Stocks Post Mixed Q2 Earnings

Ingredients, flavors, and fragrances companies reported mixed second-quarter results, with the five tracked stocks missing revenue consensus estimates by 2.4% as a group. Darling Ingredients posted revenue of $1.72 billion, up 16.4% year over year and beating expectations by 0.5%, though EBITDA missed significantly. Archer-Daniels-Midland delivered the best quarter with revenue of $22.68 billion, up 7.2% and 2.2% above estimates, while International Flavors & Fragrances was the weakest, with revenue down 29.3% to $1.95 billion and missing by 25%. Ingredion reported flat revenue of $1.85 billion, topping estimates by 0.9%, and Bunge Global grew revenue 88.3% to $24.04 billion, beating by 9.3%. Shares of the group have risen 4.9% on average since the latest earnings results.
Yahoo Finance·6dRead more ▾
IFF

IFF Misses Q2 Estimates, Slashes Guidance After Food Ingredients Divestiture

International Flavors & Fragrances reported second-quarter results that missed analyst expectations and cut its full-year guidance following the divestiture of its Food Ingredients business. Revenue fell 29.3% year over year to $1.95 billion, well below the $2.61 billion consensus, while adjusted EPS of $0.82 missed the $1.12 estimate. The company lowered its full-year revenue guidance to $7.5 billion at the midpoint from $10.65 billion, and set EBITDA guidance of $1.57 billion, below analyst estimates of $2.11 billion. Management attributed temporary margin pressure to stranded costs from the divestiture, with CEO Jon Erik Fyrwald saying two-thirds of those costs will be removed in year one. Organic revenue rose 6% year over year, and the company highlighted volume growth across its Scent, Taste, and Health & Biosciences divisions.
StockStory·14dRead more ▾
IFF2

IFF reports 6% sales growth, sets $2.5 billion buyback and 2026 outlook

International Flavors & Fragrances reported second-quarter continuing-operations sales rose 6% to nearly $2 billion and adjusted operating EBITDA increased 6% to $408 million, driven by volume growth across all segments. The company is selling its Food Ingredients business to CVC Capital Partners for approximately $4.3 billion, retaining a 10% stake, and plans to use more than $1 billion of proceeds to reduce debt while addressing about $100 million in stranded costs. IFF introduced full-year 2026 guidance for continuing operations, projecting sales of $7.4 billion to $7.6 billion and EBITDA of $1.53 billion to $1.6 billion. The board authorized a $2.5 billion share-repurchase program, with about $500 million expected to be repurchased in the second half of 2026. The company also announced an agreement to sell a portfolio of non-strategic products with about $170 million in annual sales for approximately $75 million, expected to close in the fourth quarter of 2026.
MarketBeat·18dRead more ▾
IFF

IFF Misses Q2 Sales Estimates and Slashes Full-Year Revenue Guidance

International Flavors & Fragrances reported second-quarter revenue of $1.95 billion, missing analyst estimates of $2.61 billion and marking a 29.3% year-on-year decline. The company lowered its full-year revenue guidance to $7.5 billion at the midpoint, down from $10.65 billion and 30.2% below analyst expectations. Adjusted earnings per share came in at $0.82, 26.6% below the consensus estimate of $1.12, while adjusted EBITDA of $408 million missed forecasts by 22.9%. Organic revenue rose 6% year on year, beating estimates, and free cash flow margin improved to 14.6% from 5.3% a year earlier. The stock remained flat at $80.50 following the release.
Yahoo Finance·22dRead more ▾
IFF

International Flavors to Report Q2 Earnings With Positive Surprise Prediction

International Flavors & Fragrances is set to report second-quarter 2026 results on August 4 after the closing bell. The Zacks Consensus Estimate for sales is $2.68 billion, a 2.9% decline from the prior year, while the earnings estimate of $1.14 per share indicates a 0.9% year-over-year drop. Zacks Investment Research's model predicts an earnings beat, citing a positive Earnings ESP of +0.73% and a Zacks Rank of 3. Segment projections show mixed performance, with the Taste segment's sales expected to rise 2.6% to $647 million, the Food Ingredient segment's sales dipping 5.4% to $804 million, the Scent segment's sales increasing 3.5% to $624 million, and the Health & Biosciences segment's sales growing 4.3% to $601 million. The company has been experiencing volume growth and cost-reduction benefits, though high raw material and other costs may have pressured margins.
Zacks Investment Research·26dRead more ▾
IFF

IFF declares $0.40 quarterly dividend for third quarter 2026

IFF announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock. The dividend is payable on October 9, 2026 to shareholders of record as of September 18, 2026.
Business Wire·29dRead more ▾
IFF2

IFF to sell botanical extracts and vitamins division to SuanNutra

International Flavors & Fragrances has agreed to sell its portfolio of botanical extracts, vitamins and minerals, and food enhancement activities to SuanNutra, a Carbyne Equity Partners portfolio company, for an undisclosed sum. The portfolio serves food, beverage, and nutritional end markets and generated approximately $170 million in revenues in 2025. The transaction includes five manufacturing facilities in Europe, the U.S., and Latin America. CEO Erik Fyrwald said the sale is another step in optimizing the portfolio and reinforces the company's focus on its core innovation-led businesses of Taste, Scent, and Health & Biosciences.
Seeking Alpha·37dRead more ▾
IFF

StockStory Targets Wabtec as S&P 500 Buy While Flagging Akamai and IFF as Sells

StockStory highlights Westinghouse Air Brake Technologies, known as Wabtec, as an S&P 500 stock to target this week, while pointing to Akamai Technologies and International Flavors & Fragrances as facing challenges. Wabtec, with a market cap of $44.07 billion, is praised for 9.1% annual revenue growth over five years, an operating margin expansion of 4.3 percentage points, and share buybacks driving 19.9% annual earnings per share growth. Akamai, valued at $17.45 billion, is flagged for weak billings growth of 6.8%, a low gross margin of 58.3%, and an expected 25.3 percentage point drop in free cash flow margin. International Flavors & Fragrances, at a $19.23 billion market cap, faces a 4.1% annual revenue decline over three years, flat expected revenue, and negative returns on capital.
StockStory·41dRead more ▾
IFF

Heartland Mid Cap Value Fund calls IFF a discounted self-help opportunity

Heartland Mid Cap Value Fund highlighted International Flavors & Fragrances as a new deep-value holding in its second-quarter 2026 investor letter. The fund noted that IFF trades at 12.23 times forward EBITDA, a steep discount to industry leader Givaudan at 19.14 times, following more than two years of portfolio streamlining toward higher-margin businesses. IFF’s profits are now split across Taste at 30%, Health & Biosciences at 37%, and Scent at 32%, with encapsulated fragrance technology driving leadership in fabric care and expansion into scent boosters, shampoos, and body washes. Management recently instituted the company’s first share buyback program in six years, signaling confidence in closing the valuation gap. The fund returned 9.90% in the quarter versus the Russell Midcap Value Index’s 13.40%, with underperformance driven by negative stock selection.
Insider Monkey·42dRead more ▾
IFF

Encapsulated Essential Oils for Feed Market to Reach $1.67 Billion by 2030

The global encapsulated essential oils for feed market is projected to grow from an estimated $1.18 billion in 2026 to $1.67 billion by 2030, at a compound annual growth rate of 9.1%, according to a new report from ResearchAndMarkets.com. The report covers 16 countries and eight regions, analyzing product types including microencapsulated, nanoencapsulated, and macroencapsulated forms, with detailed subsegment breakdowns such as spray-dried microcapsules, nanoemulsions, and extruded capsules. Key companies profiled include Cargill Incorporated, Archer-Daniels-Midland Company, DSM-Firmenich AG, International Flavors & Fragrances Inc., and Symrise AG. The study highlights drivers such as the shift toward antibiotic-free livestock production, adoption of natural feed additives for gut health, and demand for controlled-release encapsulation technologies. Expanded geographic coverage includes Taiwan and Southeast Asia, reflecting ongoing manufacturing shifts and supply chain realignments.
GlobeNewswire·43dRead more ▾
IFF

Morgan Stanley and Argus Raise Price Targets on International Flavors & Fragrances

Morgan Stanley and Argus have raised their price targets on International Flavors & Fragrances. On July 1, 2026, Morgan Stanley lifted its target to $95 from $93, maintaining an Overweight rating, citing adjusted estimates and higher peer multiples. A day earlier, Argus increased its target to $85 from $80 with a Buy rating, noting the shares are trading near the low end of their historical valuation range and that volume growth and productivity gains can drive sustained earnings growth. Also on June 30, IFF launched SENSORA, an advanced patent-pending pro-fragrance technology for home, fabric, and personal care applications, designed to deliver a longer-lasting and more sophisticated scent experience.
Insider Monkey·43dRead more ▾
IFF

International Flavors & Fragrances beats Q1 estimates, stock jumps 18.4%

International Flavors & Fragrances reported first-quarter revenues of $2.74 billion, down 3.6% year on year but exceeding analysts' expectations by 3.9%, with strong beats on EBITDA and organic revenue estimates. Among the five ingredients, flavors and fragrances stocks tracked, the group's revenues were in line with consensus, though share prices have fallen 3.3% on average since reporting. Bunge Global posted the fastest revenue growth at $21.86 billion, up 87.8% year on year, but missed revenue estimates by 3.1% and its stock fell 15.7%. Ingredion's revenues of $1.79 billion, down 1.2%, were in line with expectations, but it significantly missed EBITDA and gross margin estimates, sending shares down 8.7%. Archer-Daniels-Midland reported $20.49 billion in revenues, up 1.6%, missing estimates by 1.2% with misses on gross margin and EBITDA, leaving its stock flat. Darling Ingredients' revenues rose 12.3% to $1.55 billion, in line with expectations, but a significant miss on adjusted operating income pushed shares down 10%.
Yahoo Finance·51dRead more ▾
IFF

IFF Launches SENSORA Pro-Fragrance Technology for Long-Lasting Scent

International Flavors & Fragrances has launched SENSORA, a patent-pending pro-fragrance technology designed to extend scent for up to 20 days post-activation across home, fabric, and personal care applications. The first product under this portfolio is Floral Fusion, a light-activated pro-fragrance for liquid detergents that releases floral notes on dry fabrics. In its first-quarter 2026 results, IFF reported adjusted earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.08, while net sales of $2.741 billion exceeded the $2.65 billion consensus despite a 3.6% year-over-year decline. The Scent segment saw sales rise 6% to $651 million, with adjusted operating EBITDA up 5% to $148 million.
Zacks Investment Research·55dRead more ▾